{"title":"雷扎芬净对一例念珠菌性脊柱盘根炎的疗效。","authors":"Marin Lahouati, Claire Tinévez, Frédéric Gabriel, Fabien Xuereb, Maxime Lefranc, Frédéric-Antoine Dauchy","doi":"10.5194/jbji-9-213-2024","DOIUrl":null,"url":null,"abstract":"<p><p>Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of <i>Candida glabrata</i> spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"9 5","pages":"213-215"},"PeriodicalIF":1.8000,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555426/pdf/","citationCount":"0","resultStr":"{\"title\":\"Efficacy of rezafungin in a case of <i>Candida</i> spondylodiskitis.\",\"authors\":\"Marin Lahouati, Claire Tinévez, Frédéric Gabriel, Fabien Xuereb, Maxime Lefranc, Frédéric-Antoine Dauchy\",\"doi\":\"10.5194/jbji-9-213-2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of <i>Candida glabrata</i> spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.</p>\",\"PeriodicalId\":15271,\"journal\":{\"name\":\"Journal of Bone and Joint Infection\",\"volume\":\"9 5\",\"pages\":\"213-215\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-10-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11555426/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Bone and Joint Infection\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5194/jbji-9-213-2024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone and Joint Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5194/jbji-9-213-2024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Efficacy of rezafungin in a case of Candida spondylodiskitis.
Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of Candida glabrata spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.